EMA Authorised: Dimethyl fumarate Accord (dimethyl fumarate) — Accord Healthcare Ltd

View source ↗

Summary

The EMA authorised a Dimethyl fumarate product from Accord Healthcare Ltd for the treatment of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Dimethyl fumarate Accord (dimethyl fumarate)

Snippet

Status: Authorised. Therapeutic area: Multiple Sclerosis. MAH: Accord Healthcare Ltd. Decision date: 25/08/2025